Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIOP) Income from Non-Controlling Interests (2016 - 2025)

Historic Income from Non-Controlling Interests for Fortress Biotech (FBIOP) over the last 11 years, with Q3 2025 value amounting to -$3.0 million.

  • Fortress Biotech's Income from Non-Controlling Interests rose 7846.97% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.7 million, marking a year-over-year decrease of 12202.64%. This contributed to the annual value of $74.9 million for FY2024, which is 1995.25% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Income from Non-Controlling Interests is -$3.0 million, which was up 7846.97% from -$27.1 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Income from Non-Controlling Interests peaked at $167.3 million during Q4 2023, and registered a low of -$224.2 million during Q4 2022.
  • Moreover, its 5-year median value for Income from Non-Controlling Interests was -$14.1 million (2025), whereas its average is -$16.0 million.
  • Data for Fortress Biotech's Income from Non-Controlling Interests shows a peak YoY increase of 24740.98% (in 2021) and a maximum YoY decrease of 26710.81% (in 2021) over the last 5 years.
  • Over the past 5 years, Fortress Biotech's Income from Non-Controlling Interests (Quarter) stood at -$163.3 million in 2021, then tumbled by 37.28% to -$224.2 million in 2022, then surged by 174.64% to $167.3 million in 2023, then crashed by 88.32% to $19.6 million in 2024, then plummeted by 115.23% to -$3.0 million in 2025.
  • Its last three reported values are -$3.0 million in Q3 2025, -$27.1 million for Q2 2025, and -$14.1 million during Q1 2025.